ATP2A1 and cancer: We found that HMGA2 was strongly positively correlated, while ATP2A1 was demonstrated to be strongly negatively correlated with IC50 values of all 30 CTRP small-molecule drugs, suggesting sharply contrasting roles of the former compared to the latter in modulating the sensitivity of cancer cell lines to therapy.